Gene Vision
  • Information and support
    • Chatbot
    • The eye
    • How to see a genetic eye specialist?
    • Coping with sight loss
    • Eye Clinic Liaison Officers (ECLOs)
    • Education and learning
    • Employment support
    • Family support service (FSS)
    • Registration for sight impairment
    • Charles Bonnet Syndrome (CBS)
    • Driving and alternative transport
  • Conditions
  • Genetics
    • Genetics basics and inheritance pattern
    • Genetic counselling and genetic testing: for patients
    • Family planning
    • Genetic counselling: for professionals
    • Clinical genetic testing: for professionals
  • Gene cards
    • Retinal dystrophies
    • Microphthalmia, anophthalmia, coloboma (MAC) and aniridia
    • Cataract and lens associated
    • Anterior segment dysgenesis including glaucoma
    • Albinism
  • Research
    • Therapies under research
    • Searching for current research or trials
    • Research Opportunities At Moorfields
  1. Home
  2. Knowledge Base
  3. USH2A
Searching...
  • Retinitis pigmentosa: for professionals

    Retinitis pigmentosa is a genetically heterogenous group of inherited retinal dystrophies mainly characterised by predominant rod impairment initially followed by subsequent cone dysfunction. Over 80 genes have been attributed to RP resulting in significant clinical heterogeneity. 20-30% of patients have syndromic RP. The most common are Usher syndrome and Bardet-Biedl syndrome.
  • Usher syndrome: for professionals

    Usher syndrome is a group of inherited disorders characterised by a combination of sensorineural hearing loss and retinitis pigmentosa.
  • RNA therapy

    RNA is involved in protein production from DNA in human cells. Mutations in DNA can be passed down to RNA, and a non-functional protein might be produced. RNA therapies target these "mistakes" in the RNA so that a normal functional protein can be produced instead.
  • USH2A gene

©2020 Copyright Gene Vision. Read our privacy policy and accessibility statement.